TissUse provides a range of products which feature miniaturized constructs that closely simulate the activity of multiple human organs in their true physiological context at the smallest possible scale.
TissUse 2-Organ-Chip for simultaneous cultivation of up to two organ equivalents connected to one another either by micro-channels or by vasculature in their true physiological context.
TissUse 4-Organ-Chip for easy integration of up to four organ-equivalents connected to one another either by micro-channels or by vasculature in their true physiological context.
The next generation of Multi-Organ-Chips at TissUse aims for a human mini-organism-on-a-chip, increasing the number of interconnected organs toward acceptable organismal complexity.
TissUse is additionally applying its platform and know-how to develop spin-off programs in a variety of tissue and organ repair areas starting with the cosmetic market of hair transplants.
TissUse`s SHT is the first organoid therapy for hereditary hair loss (androgenetic alopecia) on the basis of autologous, in vitro multiplied and reassembled human dermal papilla organoids.